Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ampersand Capital Partners and 1315 Capital, has completed the acquisition of Genoptix, Inc. from Novartis. The financial terms of the transaction are not being disclosed.
read more
Amphastar announced the FDA has approved its ANDA for Succinylcholine Chloride Injection USP, 200 mg/10 mL Multiple-Dose Vial.
read more
Wednesday, February 06, 2019
Amplicare announced the addition of two new benefits to its suite of solutions aimed at helping pharmacists improve patient care and health outcomes.
read more
Tuesday, September 10, 2019
AMRA has entered into an exclusive agreement with Micro, to guide and support pharmaceutical and research clients in Japan with clinical trials.
read more
Albany Molecular Research, Inc. announces expanded access to its accelerated solutions platform, spanning research & development to manufacturing for orphan and rare disease products.
read more
Albany Molecular Research Inc. (AMRI) and Icagen, Inc. have signed a collaboration agreement to co-market Icagen's ion channel and transporter technology to global pharmaceutical and biotechnology clients.
read more
Thursday, December 10, 2015
Albany Molecular Research Inc. (AMRI) has signed a collaboration agreement with biotechnology company Multispan Inc. to co-market their G protein-coupled receptor (GPCR) drug discovery services to global pharmaceutical and biotechnology clients.
read more
Thursday, January 14, 2016
Albany Molecular Research Inc. (AMRI) has signed a collaboration agreement with the New York Center for Nanomedicine Research (NYCNMR) to co-market their nanotechnology services to global pharmaceutical and biotechnology clients.
read more
Albany, NY (April 23, 2013) — AMRI announced today that it has entered into a new five-year service agreement with Ono Pharmaceutical Company, Ltd., (TSE: 4528), a pharmaceutical company headquartered in Osaka, Japan. Under the terms of the agreement...
read more
Wednesday, January 13, 2016
AMRI has announced the extension of a key insourcing relationship with a major pharmaceutical company designed to accelerate their chemistry and drug discovery efforts.
read more
Tuesday, February 21, 2017
AMRI has entered into an agreement with the pharmaceutical group Ferrer and Accord Healthcare, Inc. to jointly develop and manufacture an undisclosed complex parenteral drug product for registration and subsequent commercialization in the United ...
read more
Tuesday, November 29, 2016
AMRI has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing, Inc. which product has been in AMRI's portfolio through the required stages of development.
read more
AMRI, a leading global contract research and manufacturing organization, has announced that the Board of Directors has unanimously voted to separate the role of Chairman and Chief Executive Officer and has named William S. Marth, an active member of ...
read more
Monday, December 09, 2019
AMRI announced John Ratliff has been named as chief executive officer, effective today, Dec. 2, 2019.
read more
AMRI has announced the appointment of Prakash Pandian as chief information officer.
read more